(Q39850018)

15 September 2017

title

Interleukin-18 as a predictor of future events in patients with acute coronary syndromes (English)

1 reference

15 September 2017

Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes (English)

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

17 June 2024

2

Olov Wiklund

1 reference

15 September 2017

6

Johan Herlitz

1 reference

15 September 2017

Marianne Hartford

1

1 reference

15 September 2017

Lillemor Mattsson Hultén

3

1 reference

15 September 2017

Anita Persson

4

1 reference

15 September 2017

Thomas Karlsson

5

1 reference

15 September 2017

Johannes Hulthe

7

1 reference

15 September 2017

Kenneth Caidahl

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

5 August 2010

1 reference

full work available at URL

15 September 2017

https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.109.202697

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20689079

http://intl-atvb.ahajournals.org/cgi/content/abstract/30/10/2039

17 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20689079

https://www.ahajournals.org/doi/full/10.1161/ATVBAHA.109.202697

17 June 2024

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Arteriosclerosis, Thrombosis, and Vascular Biology

17 June 2024

published in

1 reference

15 September 2017

volume

30

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

2039-2046

1 reference

Inflammation, atherosclerosis, and coronary artery disease

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

17 June 2024

2

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

17 June 2024

3

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice

17 June 2024

4

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6.

17 June 2024

5

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Associations of serum IL-18 levels with carotid intima-media thickness

17 June 2024

7

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

17 June 2024

8

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

17 June 2024

9

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

17 June 2024

10

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome

17 June 2024

11

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up

17 June 2024

12

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

17 June 2024

13

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Spectrum of acute coronary syndromes: history and clinical presentation in relation to sex and age

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Does interleukin-18 or tumour necrosis factor-α have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand

17 June 2024

15

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease

17 June 2024

16

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

17 June 2024

17

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

European Cytokine Network

17 June 2024

18

11

15

2000

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression

17 June 2024

20

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.

17 June 2024

21

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty

17 June 2024

22

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

The role of neutrophils in severe sepsis

17 June 2024

23

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice

17 June 2024

24

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure.

17 June 2024

25

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury

17 June 2024

26

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1161/ATVBAHA.109.202697

17 June 2024

Identifiers

1 reference

15 September 2017

1 reference